BioSpace News Archive

Pharm Country

FDA Clearance Awarded to Tyber Medical for NiTy+ One-Shot Staple Fixation System

Tyber Medical LLC, the global, leading private-label medical device provider for major orthopedic trauma, extremity, and spine companies, has been awarded a U.S. Food and Drug Administration (FDA) 510(k) clearance for its new NiTy+ One-Shot™ Staple Fixation System.

November 15, 2022
·
3 min read
BioMidwest

Kraig Biocraft Laboratories poised to Close Out Yorkville Convertible Debenture with Strongest Financial Position in Corporate History

Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that it has nearly closed out its $8 million in convertible debenture with Yorkville Advisors.

November 15, 2022
·
2 min read
Business

Bio-Techne Announces Opening of New Immunoassay Manufacturing Facility

Bio-Techne Corporation announced the opening of its new 52,000 square foot state-of-the-art product innovation and manufacturing facility.

November 15, 2022
·
2 min read
Business

HanAll Biopharma Reports Third Quarter 2022 Results and Provides Business Update

HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company developing innovative medicines, today reported financial results for the third quarter of 2022 and provided recent business updates.

November 15, 2022
·
9 min read
Genetown

Omega Therapeutics Named One of BioSpace’s 2023 Best Places to Work

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as a new class of programmable epigenetic medicines, today announced that it has been named among BioSpace’s Best Places to Work.

November 15, 2022
·
6 min read
Business

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Virax Biolabs announced today the appointment of Richard Pallin as Vice President of In Vitro Diagnostic Sales.

November 15, 2022
·
4 min read
Biotech Bay

Better Therapeutics to Participate in BTIG Digital Health Forum

Better Therapeutics, Inc. today announced that Frank Karbe, Chief Executive Officer, and Mark Berman, MD, Chief Medical Officer, will participate in a virtual fireside chat at the BTIG Digital Health Forum on Monday, November 21, 2022, at 2:00 p.m. ET / 11:00 a.m. PT.

November 15, 2022
·
1 min read
Business

ElevateBio and Affini-T Therapeutics Announce Partnership to Advance Affini-T’s T Cell Therapy Programs Targeting Core Oncogenic Drivers

ElevateBio, LLC and Affini-T Therapeutics, today announced a partnership to advance Affini-T’s engineered TCR-T therapies focused on KRAS (Kirsten rat sarcoma viral oncogene homolog), one of the most prevalent oncogenic driver mutations in solid tumor cancers.

November 15, 2022
·
5 min read
Pharm Country

Organon To Present at the Piper Sandler 34th Annual Healthcare Conference

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Piper Sandler 34 th Annual Healthcare Conference on Tuesday, November 29th, 2022 at 9:00 a.m. EST.

November 15, 2022
·
1 min read
Pharm Country

Soligenix to Receive $1.2 M in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

Soligenix, Inc. announced today that it has received preliminary approval for a tax credit from the New Jersey Economic Development Authority’s (NJEDA) New Jersey Technology Business Tax Certificate Transfer program.

November 15, 2022
·
7 min read